Skip to main content

Table 3 Univariate analysis of normalized KOOS for 13 patients suffering from KOA treated with BM-MSCs

From: Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study

Normalized KOOS sections Baseline (mean) 6th month follow-up (mean) P value 1 year follow-up (mean) P value 2 years follow-up (mean) P value
Symptoms 67.300 91.2308 0.000 89.9 0.000 88.7 0.000
Pain 62.585 89.0538 0.000 89.7 0.000 89.4 0.000
Daily life activity 64.223 90.8308 0.000 92.2 0.000 93 0.000
Sport 40.25 79.9769 0.000 81.1 0.000 81.6 0.000
Quality of life 34.162 75.4923 0.000 76.9 0.000 77.4 0.000